Bright Huo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bright Huo has a total of 275 co-authors. Here are the top co-authors by number of shared publications:
Stavros A. Antoniou
Department of Surgery, Papageorgiou General Hospital, Thessaloniki, Greece
15 shared publicationsDimitris Mavridis
Guidelines Committee, European Association for Endoscopic Surgery, Eindhoven, The Netherlands
11 shared publicationsGordon Guyatt
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
11 shared publicationsPatricia Sylla
Division of Colon and Rectal Surgery, Icahn School of Medicine at Mount Sinai, New York, USA
7 shared publicationsMonica Ortenzi
Università Politecnica delle Marche, Clinica di Chirurgia Generale e d'Urgenza, Italy
6 shared publicationsYegor Tryliskyy
Southmead Hospital, Bristol, UK
6 shared publications
Latest Publications
- Open Access
- 14 November 2026
- Published by Elsevier in Intelligent Medicine
Agentifiability: Testing whether scientific records support independent reconstruction by artificial intelligence agents
- 14 November 2026
- Published by Elsevier in Intelligent Medicine
Open AccessAgentifiability: Testing whether scientific records support independent reconstruction by artificial intelligence agents
- Open Access
- 3 November 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
The CHART reporting guideline: the flow must go on
Was not provided for this article.
- 3 November 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
Open AccessThe CHART reporting guideline: the flow must go on
Was not provided for this article.
- 14 October 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (11) , 9300-9314
EAES-SAGES clinical practice guideline update: multi-society recommendations on key controversies in the management of diverticular disease
- 14 October 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (11) , 9300-9314
EAES-SAGES clinical practice guideline update: multi-society recommendations on key controversies in the management of diverticular disease
- Open Access
Consensus project to develop a reporting checklist extension for collaboratively developed guidelines: protocol
Introduction: Current reporting standards for guidelines include the Appraisal of Guidelines for Research and Evaluation Tool and the Reporting Items for Practice Guidelines in HealThcare Checklist. These recommend the minimum items that should be reported by clinical practice guideline developers. However, the reporting of guidelines that are developed between two or more organisations sharing responsibilities varies in quality and completeness regarding the documentation of the collaboration process. We aim to develop an extension document for the reporting of guidelines in which two or more groups share responsibilities and resources for development and dissemination. Methods and analysis: A scoping review of literature relevant to collaboratively developed guidelines over the past 10 years will be conducted, adherent to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Scoping Review Statement, to inform a long list of possible elements to be included in this extension. The qualitative data from focus group sessions among steering committee members will inform the initial list before removal of duplications and iterative amendments. A representative international, multidisciplinary group of key partners will then participate in a Delphi survey to identify a critical short list of reporting elements. All panel and steering committee members will be later invited to a consensus conference to review the provisionally included elements for final inclusion in a list of extension items. Steering committee members will then conduct a pilot of the final extension. Ethics and dissemination: The Northwestern University Institutional Review Board determined that this study does not constitute human subjects research (STU00224953). The final extension instrument and explanation and elaboration document will be disseminated through peer-reviewed publication, the Guidelines International Network website as a free public resource, social media and outreach to journals and guideline-developing organisations.
Open AccessConsensus project to develop a reporting checklist extension for collaboratively developed guidelines: protocol
Introduction: Current reporting standards for guidelines include the Appraisal of Guidelines for Research and Evaluation Tool and the Reporting Items for Practice Guidelines in HealThcare Checklist. These recommend the minimum items that should be reported by clinical practice guideline developers. However, the reporting of guidelines that are developed between two or more organisations sharing responsibilities varies in quality and completeness regarding the documentation of the collaboration process. We aim to develop an extension document for the reporting of guidelines in which two or more groups share responsibilities and resources for development and dissemination. Methods and analysis: A scoping review of literature relevant to collaboratively developed guidelines over the past 10 years will be conducted, adherent to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Scoping Review Statement, to inform a long list of possible elements to be included in this extension. The qualitative data from focus group sessions among steering committee members will inform the initial list before removal of duplications and iterative amendments. A representative international, multidisciplinary group of key partners will then participate in a Delphi survey to identify a critical short list of reporting elements. All panel and steering committee members will be later invited to a consensus conference to review the provisionally included elements for final inclusion in a list of extension items. Steering committee members will then conduct a pilot of the final extension. Ethics and dissemination: The Northwestern University Institutional Review Board determined that this study does not constitute human subjects research (STU00224953). The final extension instrument and explanation and elaboration document will be disseminated through peer-reviewed publication, the Guidelines International Network website as a free public resource, social media and outreach to journals and guideline-developing organisations.
- 9 September 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (11) , 3925
Consensus framework for the validation of generative AI: call for collaborators on the Validation Accords
- 9 September 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (11) , 3925
Consensus framework for the validation of generative AI: call for collaborators on the Validation Accords
- 1 September 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (10) , 8257-8272
Systematic review and meta-analysis on key controversies in the management of diverticular disease: a multi-society collaboration
- 1 September 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (10) , 8257-8272
Systematic review and meta-analysis on key controversies in the management of diverticular disease: a multi-society collaboration
- 31 August 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (10) , 8250-8256
European Association of Endoscopic Surgery (EAES) Clinical Practice Guidelines Committee: standard operating procedure
- 31 August 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (10) , 8250-8256
European Association of Endoscopic Surgery (EAES) Clinical Practice Guidelines Committee: standard operating procedure
- 20 July 2026
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 198
Chatbot Health Advice Studies: what are they, how are they evolving in health care, and how do we respond?
- 20 July 2026
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 198
Chatbot Health Advice Studies: what are they, how are they evolving in health care, and how do we respond?
- Open Access
- 2 July 2026
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 39 (4)
Endoscopic resection versus esophagectomy for T1bN0M0 esophageal cancer: a systematic review and meta-analysis
Summary: Esophagectomy remains the standard of care for T1b esophageal cancer. Guidelines support the use of endoscopic resection (ER) including endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) in carefully selected patients. We compared patients with T1b esophageal cancer who underwent ER or esophagectomy. We searched MEDLINE, EMBASE and CENTRAL from inception to November 2025 for studies comparing esophagectomy and ER for patients with T1b esophageal cancer. We excluded studies if patients received neoadjuvant or adjuvant treatment. Outcomes were 5-year overall survival (OS) and cancer specific survival (CSS), recurrence, and mortality. Meta-analysis (with propensity-matched data when available) was performed, with a subgroup analysis of ESD versus esophagectomy. Ten retrospective studies were identified comprising 2491 patients who underwent ER (n = 890) or esophagectomy (n = 1601). Mean age was 65.7 years with 16.1% female. Six studies grouped EMR and ESD together, three reported ESD alone, one examined EMR only. OS and CSS were available in seven and four studies, respectively. There was no significant difference between esophagectomy and ER regarding 5-year OS (HR 1.26; 95% CI 1.00–1.60; P = 0.05), 5-year CSS (HR 0.65; 95% CI 0.20–2.17; P = 0.49), and 30-day mortality (HR 0.39; 95% CI 0.13–1.16; P = 0.09). Recurrence was 18.1% after esophagectomy and 17.7% after ER. Subgroup analysis showed no difference in OS or mortality. Risk of bias was high in five studies. Available retrospective comparative evidence suggests no clear difference between ER and esophagectomy for patients with T1b esophageal cancer. Randomized controlled trials are needed to reduce patient heterogeneity.
- 2 July 2026
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 39 (4)
Open AccessEndoscopic resection versus esophagectomy for T1bN0M0 esophageal cancer: a systematic review and meta-analysis
Summary: Esophagectomy remains the standard of care for T1b esophageal cancer. Guidelines support the use of endoscopic resection (ER) including endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) in carefully selected patients. We compared patients with T1b esophageal cancer who underwent ER or esophagectomy. We searched MEDLINE, EMBASE and CENTRAL from inception to November 2025 for studies comparing esophagectomy and ER for patients with T1b esophageal cancer. We excluded studies if patients received neoadjuvant or adjuvant treatment. Outcomes were 5-year overall survival (OS) and cancer specific survival (CSS), recurrence, and mortality. Meta-analysis (with propensity-matched data when available) was performed, with a subgroup analysis of ESD versus esophagectomy. Ten retrospective studies were identified comprising 2491 patients who underwent ER (n = 890) or esophagectomy (n = 1601). Mean age was 65.7 years with 16.1% female. Six studies grouped EMR and ESD together, three reported ESD alone, one examined EMR only. OS and CSS were available in seven and four studies, respectively. There was no significant difference between esophagectomy and ER regarding 5-year OS (HR 1.26; 95% CI 1.00–1.60; P = 0.05), 5-year CSS (HR 0.65; 95% CI 0.20–2.17; P = 0.49), and 30-day mortality (HR 0.39; 95% CI 0.13–1.16; P = 0.09). Recurrence was 18.1% after esophagectomy and 17.7% after ER. Subgroup analysis showed no difference in OS or mortality. Risk of bias was high in five studies. Available retrospective comparative evidence suggests no clear difference between ER and esophagectomy for patients with T1b esophageal cancer. Randomized controlled trials are needed to reduce patient heterogeneity.